All News

People age 50 and older should now receive the shingles vaccine, according to a new recommendation by the American Academy of Ophthalmology and the American Dermatological Association, which lowers the recommended age by 10 years.

Robert Dubois, MD, PhD, chief science officer of the National Pharmaceutical Council (NPC), has advised the Department of Veterans Affairs (VA) to be cautious when using the information provided by the Institute for Clinical and Economic Review (ICER)’s drug assessment reports to inform formulary decisions.

While exercise tends to taper off after age 65, the findings show the mental health benefits are greater for seniors who keep moving, which is an important lesson for health professionals.

A new commentary suggests that interventions to promote physical activity in survivors of cancer should be delivered at home and guided by oncologists.

Consumers spend $2 billion worldwide on body moisturizers each year, but a new study found that many skin-quenching products marketed as hypoallergenic or fragrance free actually contain some of the allergens known to pose a risk of contact dermatitis.

Obesity and overweight in individuals were associated with a lower risk and frequency of chronic pulmonary obstructive disease (COPD) exacerbations in Taiwan.

Experiments with baker's yeast showed why a fat-regulating enzyme is needed in the body.

Salt intake may be associated with an increased risk of developing diabetes. Research presented at the annual meeting of the European Association for the Study of Diabetes and published in Diabetologia found sodium intake increased the risk of developing both type 2 diabetes and latent autoimmune diabetes in adults.

While many payers, and the Blues in particular, have invested in digital health startups, a new agreement will pair Horizon with a company whose philosophy rejects the operating mentality of most insurers.

The product for the treatment of attention-deficit hyperactivity disorder (ADHD) needs no refrigeration or reconstitution at the pharmacy level.

New results published in CDC’s Morbidity and Mortality Weekly Report have identified a surge in pediatric acute lymphoblastic leukemia (ALL) during the period 2001 to 2008, followed by stabilization during 2008 to 2014.

In light of rising rates of preventive mastectomies among women with breast cancer, a new study looks at whether patient and surgeon factors, including attitudes toward breast conservation, affect the odds of receiving this surgery.

The HIV Medicine Association of the Infectious Disease Society of America recently published clinical practice guidelines for managing chronic pain in patients with HIV.

There is an association between asthma and the development of Crohn’s disease and with early and late-onset ulcerative colitis, according to a recent research.

Individuals with psoriasis face a greater risk of dying because of an alcohol-related death compared with people in the general population, according to recent research.

This week, the top stories in managed care included competing healthcare reform bills in the Senate; the FDA announced progress in clearing up the backlog of orphan drug requests; and a study examines how much it really costs to bring a drug to the market.

Paying close attention to the area around the wound and frequent measurement made a difference.

Cabazitaxel can now be used at a dose of 20 mg/m2 every 3 weeks in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have received a docetaxel-based treatment regimen.

Patients with relapsed follicular lymphoma now have a new treatment option: copanlisib, a kinase inhibitor that was recently approved through the FDA’s accelerated approval process.

In the wake of Hurricane Harvey, Houston is expected to face a host of health challenges, including air pollution. Here are 5 facts about how air pollution affects people’s health.

Researchers noted that the oral therapy functions independently of insulin to carry excess blood glucose out of the system.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The FDA has approved bevacizumab-awwb (Mvasi) as a treatment for multiple cancers. The drug has been approved as a biosimilar to its reference biologic, bevacizumab (Avastin), but it has not been approved as an interchangeable product.

After CMS and Novartis devised an outcomes-based payment approach for the new chimeric antigen receptor (CAR)-T treatment tisagenlecleucel (Kymriah), a group of representatives are requesting more information on the specifics of the agreement.

The results support policy positions that diabetes self-management education and support should occur at transitions in care.

Since primary care physicians spend more than half their workday on electronic health record (EHR) tasks, employing scribes to chart data could alleviate the burden on physicians and improve efficiency.